JPMORGAN CHASE & CO - ALEXION PHARMACEUTICALS INC ownership

ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351959. A total of 6 filers reported holding ALEXION PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALEXION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$62,296,000
+535.5%
339,100
+429.0%
0.01%
+600.0%
Q1 2021$9,802,000
-42.8%
64,100
-41.5%
0.00%
-66.7%
Q4 2020$17,124,000
+38.9%
109,6000.0%0.00%
+50.0%
Q3 2020$12,326,000
-19.8%
109,600
-20.0%
0.00%
-33.3%
Q2 2020$15,377,000
+92.0%
137,000
+53.6%
0.00%
+50.0%
Q1 2020$8,009,000
-65.2%
89,200
-58.1%
0.00%
-50.0%
Q4 2019$23,014,000
+16.6%
212,800
+5.6%
0.00%0.0%
Q3 2019$19,735,000
-32.4%
201,500
-13.0%
0.00%
-33.3%
Q2 2019$29,194,000
+37.8%
231,500
+47.7%
0.01%
+50.0%
Q1 2019$21,183,000
+1.3%
156,700
-27.0%
0.00%
-20.0%
Q4 2018$20,903,000
-37.3%
214,700
-10.5%
0.01%
-16.7%
Q3 2018$33,335,000
+181.8%
239,800
+151.6%
0.01%
+200.0%
Q2 2018$11,831,000
+68.7%
95,300
+51.5%
0.00%0.0%
Q1 2018$7,011,000
-75.9%
62,900
-74.1%
0.00%
-66.7%
Q4 2017$29,048,000
-9.8%
242,900
+4.3%
0.01%
-14.3%
Q3 2017$32,219,000
-0.1%
232,900
-12.1%
0.01%0.0%
Q2 2017$32,243,000
-42.8%
265,000
-43.0%
0.01%
-46.2%
Q1 2017$56,377,000
+130.4%
465,000
+132.5%
0.01%
+116.7%
Q4 2016$24,470,000
+898.4%
200,000
+900.0%
0.01%
+500.0%
Q3 2016$2,451,00020,0000.00%
Other shareholders
ALEXION PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 149,800$23,405,0000.04%
SIMPLEX TRADING, LLC 763$11,921,0000.02%
IMC-Chicago, LLC 45,400$7,093,0000.01%
JPMORGAN CHASE & CO 109,600$17,124,0000.00%
SG Americas Securities, LLC 199,400$32,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
OSAIC HOLDINGS, INC. 2$00.00%
View complete list of ALEXION PHARMACEUTICALS INC shareholders